Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Fintech PR




The Ellinikon is delivering on key milestones amid residential sales, global investment, and commercial leasing velocity

ATHENS, Greece, March 27, 2024 /PRNewswire/ — Lamda Development is pleased to announce that works are rapidly progressing at The Ellinikon, Europe’s largest urban regeneration project and a 15-minute, smart, green coastline city being built from the ground up in Athens. With views of the blue of the Aegean Sea and breathtaking sunsets, this new world-class destination is expected to attract at least one million new tourists.


As Phase I advances well into its construction and development stage, significant progress has been made this year amid global demand from more than 50 countries. The projects due for Phase I completion include the largest part of the commercial developments, the regeneration of the Coastal Front and Agios Kosmas Marina, a large part of The Ellinikon Park, and approximately 1,500 units of residential development. Upon completion, Phase I is expected to generate approximately €3.3 billion of cash proceeds.

Lamda is also proud to have delivered the Care Centre for People with Disabilities earlier this year to the neighboring municipalities. This state-of-the-art facility is already operational, housing four associations within its 11,500 square meters. This is the first building to be developed by Lamda at The Ellinikon and was delivered on schedule—an occasion commemorated by an October visit from the Greek Prime Minister, who delivered remarks about the project’s significance.

The Riviera Tower—The Ellinikon’s crown jewel—will be the tallest skyscraper in the country and the tallest green seafront high rise on the Mediterranean. Its main works contract is awarded to the Bouygues Batiment International–INTRAKAT Joint Venture. The completion of the building’s raft foundation was achieved through a 40-hour process of continuous concrete casting, the longest such process in Greek history. Hill International has been appointed as the project’s construction supervisor.

Meanwhile, the Cove Residences received building permits for all four blocks in early 2023. Site mobilization, demolition, and excavation took place throughout 2023, while the construction of the concrete frame for the project has already commenced. Hill International has been appointed as the project management consultant.

Following the successful sale and marketing of more than 350 coastal front residential units, Lamda recently announced Little Athens, an exciting new neighborhood bringing approximately 1,115 residences and 110 neighborhood retail units to The Ellinikon’s smart urban ecosystem. As part of this, Lamda unveiled Park Rise, a 12-story, 50 meter-high, 88-residence building designed by globally renowned architecture firm Bjarke Ingels Group.

Additionally, Lamda has announced the Pavilion Terraces, a development of seven six-story residential buildings, four of which will also feature ground-floor retail. Designed by Greek architectural firm 314 Architecture Studio, the project will bring 156 one- to five-bedroom residences.

Lamda has also recently announced three new five-story developments within Little Athens, all featuring one-to four-bedroom residences with dynamic indoor-outdoor designs aligned with the neighborhood. The new properties include Promenade Heights, designed by 314 Architecture Studio and comprising 79 apartments; Atrium Gardens, designed by Deda & Architects and comprising 56 apartments and seven retail units; and Trinity Gardens, designed by Tsolakis Architects and comprising 80 apartments. The projects are targeting completion in Q4 2026.

Shopping and Leisure Destinations

Preliminary works commenced in 2023 for The Ellinikon Mall, a groundbreaking retail and entertainment destination. Throughout its advanced infrastructure, the mall will offer high-end design and a curated selection of leading Greek and international brands.

Excavation and concrete work also commenced in July 2023 on facilities at The Ellinikon’s Sports Park.


Significant progress has been made on The Ellinikon’s infrastructure. At the Poseidonos Underpass, which will unite The Ellinikon’s coastal front with its urban core, more than 70% of the total volume has been excavated with nearly 40% concreted.

Regarding site remediation, more than 1,000 cubic meters of underground water and more than 6,000 tons of soil have been treated on site. Additionally, 5.5 km of old fuel pipelines have been removed and tree transplants are in progress.

The Ellinikon will also be protected from many effects of climate change—such as flooding—through the Trachones stream, a pioneering project and part of the city’s strong flood protection system. 60% of the excavation for the flood protection systems have been completed this year, while 88% of the excavation work and 65% of the concreting work of the central rainwater collectors have also been completed.

2024 Project Updates

Lamda and its contractors are working diligently to bring The Ellinikon to life, with exciting progress planned for 2024, including:

  • Construction of the Riviera Galleria, an ultra-high-end retail and leisure development
  • Regeneration of the 3-km coastal front, including the 1.5-km long public beach
  • Development of The Ellinikon Park, the world’s largest coastal park, as well as open public areas

Video –

Cision View original content:

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Fintech PR

Invitation to presentation of EQT AB’s Q1 Announcement 2024




STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.

The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.

To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.

The webcast can be followed live here and a recording will be available afterwards.

Information on EQT AB’s financial reporting

The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.

The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.

Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]

Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision,c3956826

The following files are available for download:

Invitation to presentation of EQT AB’s Q1 Announcement 2024,c3285895

EQT AB Group


View original content:

Continue Reading

Fintech PR

Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs



  • Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
  • Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
  • Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
    • Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
    • PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
  • Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
  • 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
  • CEO reaffirms Kia’s commitment to ESG management

SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.

Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.

During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.

The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.

“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”

Photo –

Cision View original content to download multimedia:

Continue Reading

Fintech PR

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update




VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.

As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.

The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.

About BioVaxys Technology Corp.

BioVaxys Technology Corp. (, a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit and connect with us on X and LinkedIn.


Signed “James Passin
James Passin, Chief Executive Officer
Phone: +1 646 452 7054

Logo –

Cision View original content:

Continue Reading